Clinical Trial Update: Effect of Topical CBD Cream for Degenerative Hallux Disorders [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating a topical cannabidiol (CBD) cream for degenerative hallux disorders was terminated, with results posted on 2024-10-15.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hallux Rigidus
• Hallux Valgus

Drugs mentioned

• CBD topical cream (cannabidiol (CBD) topical)

Snippet

Sponsor: Rush University Medical Center | Conditions: Hallux Valgus, Hallux Rigidus | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-10-15